Review of therapeutic trends in clinical trials for hidradenitis suppurativa: the rise of biologics and demographic under-representation

Clin Exp Dermatol. 2024 Jan 25;49(2):172-173. doi: 10.1093/ced/llad337.
No abstract available

MeSH terms

  • Adalimumab / therapeutic use
  • Biological Factors / therapeutic use
  • Biological Products* / therapeutic use
  • Demography
  • Hidradenitis Suppurativa* / drug therapy
  • Hidradenitis Suppurativa* / epidemiology
  • Humans

Substances

  • Biological Products
  • Biological Factors
  • Adalimumab